Staging of renal carcinoma using magnetic resonance imaging at 1.5 tesla

19Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The preoperative magnetic resonance imaging (MRI) studies of 31 patients with surgically proven renal cell carcinomas obtained with a 1.5 Tesla unit were retrospectively reviewed to assess the accuracy of MRI for staging of tumor. According to the Robson classification 12 patients were found at surgery to have Stage I renal carcinoma, three patients had Stage II, ten had Stage IIIA, one had Stage IIIB, two had Stage IIIC, one had Stage IVA, and two had Stage IVB disease. Twenty‐five (81%) of 31 patients were staged correctly by MRI. Clearly MRI showed venous tumor extension without the need for intravenous contrast administration. Also, MRI had a negative predictive value of 95%, and a positive predictive value of 100% for the evaluation of inferior vena cava tumor thrombus. At 1.5 Tesla MRI is an excellent staging modality in the preoperative evaluation of renal carcinoma. It is especially recommended in patients with equivocal computed tomography findings and in all patients with contraindications to the intravenous use of iodinated contrast material. Copyright © 1990 American Cancer Society

Cite

CITATION STYLE

APA

Amendola, M. A., King, L. R., Pollack, H. M., Gefter, W., Kressel, H. Y., & Wein, A. J. (1990). Staging of renal carcinoma using magnetic resonance imaging at 1.5 tesla. Cancer, 66(1), 40–44. https://doi.org/10.1002/1097-0142(19900701)66:1<40::AID-CNCR2820660109>3.0.CO;2-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free